Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Longitudinal Thrombosis in End Stage Renal Disease Pilot Study

NCT00157664 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

NCT NCT00157664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00157664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Longitudinal Thrombosis in End Stage Renal Disease Pilot Study
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2004
Completion date
December 31, 2008
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, cardiovascular disease, end stage renal disease, thrombosis